When was SCL founded?

SCL was founded in 1993 and raised its 1st funding round 18 years after it was founded.

Where is SCL located?

SCL is headquartered in Dera Bassi, India. It is registered at VILL SAIDPURADERA BASSI BARWALA ROAD DERA BASSI, PUNJAB, Punjab, India, 000000.

Which legal entities is SCL associated with?

SCL is associated with SCL LIFESCIENCES LIMITED.

How many employees does SCL have?

As of Aug 31, 2025, SCL has 847 employees, reflecting a 7% year-over-year growth in headcount.

Is SCL a funded company?

SCL is a funded company, having raised a total of $3.32M across 2 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Mar 02, 2011.

How much is SCL worth?

The latest valuation of SCL is $***** as of Feb 15, 2013.

When was the latest funding round of SCL?

SCL's latest funding was a $***** Unattributed round on Feb 15, 2013, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In India, the Biopharma Outsourcing sector has seen $333M in funding in 2026 to date.

What is the annual revenue of SCL?

Annual revenue of SCL is between ₹100 Cr and ₹500 Cr as on Mar 31, 2026

Where does SCL rank among its competitors?

SCL ranks 78th amongst 958 active competitors, of which 38 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Embio, which secured $50M in May, 2026.

Who are the top competitors of SCL?

SCL's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem. Among them, Embio secured the most recent funding round in May, 2026.

SCL - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Website: sauravchemicals.com
Email ID: *****@sauravchemicals.com
Phone Number: +91 **********
Registered Address: VILL SAIDPURADERA BASSI BARWALA ROAD DERA BASSI, PUNJAB, Punjab, India, 000000

Key Metrics

Founded Year

1993

Location

Dera Bassi, India

Stage

Early Stage

Total Funding

$3.32M in 2 rounds

Latest Funding Round

Unattributed, Feb 15, 2013, $*****

Post Money Valuation

$***** as on Feb 15, 2013

Investors

Mitsubishi Corporation & 5 more

Ranked

78^th among 958 active competitors

Annual Revenue

₹100 - ₹500 Cr as on Mar 31, 2026

Employee Count

847 as on Aug 31, 2025

Similar Companies

Laurus Labs & 1222 more

View SCL's full profile

SCL is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SCL LIFESCIENCES LIMITED CIN: U24112PB1993PLC014017 , India, Active	Dec 20, 1993	₹100 - ₹500 Cr (As on Mar 31, 2026)	847 (As on Aug 01, 2025)

SCL has raised a total funding of $3.32M over 2 rounds. Its first funding round was on Mar 02, 2011. Its latest funding round was a Unattributed round on Feb 15, 2013 for $*****. 1 investor participated in its latest round. SCL has 2 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of SCL:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 15, 2013	7566109	Unattributed	8284774	9884128	1481286	9408319
Mar 02, 2011	2859701	Unattributed	9290831	4999139	Indian Voice	Udayan Sengupta & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of SCL's funding rounds and investors

The founders of SCL is Parveen Goyal.

Here are the details of SCL's key team members:

Parveen Goyal: Managing Director of SCL. They are also an angel investor in 1 startup and serve on the board of 1 company.
Contact Info: 1 email address

SCL's Board of Directors

SCL's board has 11 active members. Parveen Goyal, Udayan Sengupta, Anil Chaudhry and Nitish Mukherjee are part of team and Avtar Singh, Shweta Mehta, Saurav Goyal, Sameer Singla, Vijay Dilbagh Rai, Naohiro Yoshida and Kirpal Singh Pal are independent board members.

Here is the list of SCL's board of directors:

Name	Type	Representing	Status	Duration
Parveen Goyal	Team	-	Current	14y 5m
Anil Chaudhry	Team	-	Current	1y 1m
znsjygn	Team	-	Current	9y 7m
Udayan Sengupta	Investor	-	Current	10y 11m
Avtar Singh	Independent board member	-	Current	11y 1m
hdwpksi	Independent board member	-	Current	7y 2m
ucuzvic	Independent board member	-	Current	9y 3m
k{{woba	Independent board member	-	Current	5y 7m
ayohddt	Independent board member	-	Current	4y 6m
ssfffov	Independent board member	-	Current	9y 6m
utqeocf	Independent board member	-	Current	8y 1m

View details of SCL's Founder profiles and Board Members

SCL's employee count trend

SCL has 847 employees as of Aug 25. The total employee count is 7.0% more than what it was in Aug 24. Here is SCL's employee count trend over the years:

Uncover SCL's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SCL include Laurus Labs, Symbiotec and NGL Fine Chem. Here is the list of Top 10 competitors of SCL, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Laurus Labs 2005, Hyderabad (India), Public	Pharmaceutical and biotechnology company	$230M	F-Prime Capital, IKP Knowledge Park & 3 others	78/100
2nd	Symbiotec 2002, Indore (India), Acquired	Manufacturer of non sterile steroid hormone based APIs and intermediates	$61.1M	Franklin Templeton Investments, Actis & 21 others	64/100
3rd	NGL Fine Chem 1981, Mumbai (India), Public	CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals	-	-	59/100
4th	Neuland 1984, Hyderabad (India), Public	Manufacturer of active pharmaceutical ingredients (APIs) and peptides	-	India Capital Growth, InvAscent & 1 others	58/100
5th	Embio 1986, Mumbai (India), Late Stage	Contract research and manufacturing company engaged in APIs and chiral intermediates	$50.3M	UTI, GURU NARAYAN FINCAP & 26 others	58/100
6th	Snapdragon Chemistry 2014, Cambridge (United States), Acquired	CDMO providing API development, manufacturing, and analytical services	-	Asymchem, C2I Accelerator & 1 others	55/100
7th	SeQuent 2002, Bengaluru (India), Acquired	APIs Manufacturer	-	Nepean Capital, Thecarlylegroup.fr & 2 others	54/100
8th	ST PHARM 2008, Siheung si (South Korea), Public	CDMO providing oligonucleotide, mRNA, and small molecule services	-	E&Investment, Synergy IB investment & 1 others	54/100
9th	Hikal 1988, Mumbai (India), Public	Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates	-	IFC	53/100
10th	Enaltec Labs 2006, Mumbai (India), Acquired	Provider of complex small-volume technology-driven pharmaceutical products	$8.56M	InvAscent, Medtech Global & 7 others	52/100
78th	SCL 1993, Dera Bassi (India), Early Stage	Provider of contract based API manufacturing services	$3.32M	Mitsubishi Corporation & 5 others	39/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on SCL's competitors? Click here to see the top ones

Founders own 28.57%, Funds own 10.00%, Enterprises own 6.63% and Other People (largest shareholder) own 39.72%. The net worth of SCL's founders is INR 42.4Cr as of Feb 15, 2013.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	28.57%	42.4Cr	9202045	1111907	1098965	7398540
Parveen Goyal	8650512	3521664	1730035	7336212	2779155	4439499
Fund	10.00%	14.9Cr	1421087	5794606	6563233	8518208
Mitsubishi Corporation	2106282	7293661	6189793	5264260	5080927	9897489
Enterprise	6.63%	9.85Cr	532302	496993	629062	345592
Other People	39.72%	59Cr	4367812	1663336	8575785	9039047
Other Investors	15.08%	22.4Cr	5325692	6908506	9275336	6392384
Total	100.00%	149Cr	6443293	9693575	7845114	4857155